Canopy Growth Gets Nasdaq Minimum-Bid Notice; 180 Days to April 12, 2027
CGC is trading near its 52-week low of $0.692 (3.9% above the low).
Summary
Canopy Growth received a Nasdaq notice that its shares have traded below $1.00 for 30 straight days, giving it until April 12, 2027 to regain compliance — most likely via the reverse split shareholders vote on October 23.
Key Events · Legal and Risk Events · CGC
-
Nasdaq Minimum-Bid Deficiency Notice
Letter dated October 14, 2026 states the closing bid has been below $1.00 for the 30 consecutive business days prior, putting the company out of compliance with Nasdaq Listing Rule 5450(a)(1).
-
April 12, 2027 Compliance Deadline
The company has 180 calendar days to regain compliance, requiring a $1.00+ closing bid for a minimum of 10 consecutive business days; any reverse split must be completed at least 10 business days before the deadline.
-
Reverse Split Vote October 23
Shareholders will vote at the reconvened annual meeting on a share consolidation of one post-split share for every 5 to 15 pre-split shares; the September 25 meeting was adjourned for lack of quorum.
-
Second Compliance Window Requires Market Transfer
A further 180 days is available only if the company transfers to the Nasdaq Capital Market and meets its other continued listing standards, with written notice of intent to cure.
Analysis · CGC · Life Sciences
Nasdaq formally notified Canopy Growth on October 14, 2026 that its shares have closed below $1.00 for 30 straight business days, triggering Listing Rule 5450(a)(1). The company has until April 12, 2027 to get the bid back above $1.00 for at least 10 consecutive days, and any reverse split must be completed at least 10 business days before that deadline. The remedy is already teed up: shareholders vote October 23 on a reverse split of one new share for every 5 to 15 old shares. Approval is not assured — the September 25 meeting was adjourned for lack of quorum — and a split does not guarantee the price holds above $1.00. Failure opens a possible second 180-day window only if the company moves to the Nasdaq Capital Market and meets its other listing standards; otherwise Nasdaq can move to delist, with an appeal to a hearings panel. The stock is already trading near its 52-week low of $0.6915, so the notice confirms rather than creates the listing pressure.
How filings like this one have moved
In the 30 days to Oct 16, 2026, 36.9% of the 961 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CGC was trading at $0.72 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $320.4M. The 52-week trading range was $0.69 to $2.38. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.